ReachMD: Genotype specific persistence: Looking beyond HPV 16

"You cannot track HPV types unless you actually test for the types."
In this insightful video, Dr. Diane Harper explains why the detection of genotype-specific persistence beyond HPV 16 & 18 is critical and encourages labs to adopt FDA-approved primary HPV tests with extended genotyping, and clinicians to use the risk-based management strategies by the ASCCP.

Latest resources

Discover our latest articles, webinars, press releases and updates in women's health.

Guidelines: ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors
Cervical Cancer | Articles & Publications
Guidelines: ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors
Contemporary OB/GYN: BD Onclarity™ HPV Assay: What it means for the future of cervical cancer detection
Cervical Cancer | News & Updates
Contemporary OB/GYN: BD Onclarity™ HPV Assay: What it means for the future of cervical cancer detection
Doctor giving patient brochure
Cervical Cancer | News & Updates
Press Release: New Survey Finds Women Are Skipping Their OB/GYN Exams, Increasing Risks for Cervical Cancer